Passage Bio Appoints Michael Kamarck, Ph.D. to Board of Directors

...Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced the appointment of Michael...
Read Full Article